Ramona Schulz-Heddergott
8PUBLICATIONS
29CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Aug 20, 2025
Targeting macrophage migration inhibitory factor as a potential therapeutic strategy in colorectal cancer.Kim Lucia Schneider, Luisa Claus, Richard Bucala
|Jul 04, 2025
TP53 missense-specific transcriptional plasticity drives resistance against cell cycle inhibitors in pancreatic cancer.Laura Urbach, Lena Wieland, Frederike Penz
|Apr 09, 2025
Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition.Tamara Isermann, Kim Lucia Schneider, Florian Wegwitz
|Mar 11, 2024
Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition.Tamara Isermann, Kim Lucia Schneider, Florian Wegwitz
|Jun 02, 2023
CDK4/6 inhibition confers protection of normal gut epithelia against gemcitabine and the active metabolite of irinotecan.Joshua Blume, Luisa Claus, Tamara Isermann
|Feb 03, 2023
The NFIA-ETO2 fusion blocks erythroid maturation and induces pure erythroid leukemia in cooperation with mutant TP53.Maria-Riera Piqué-Borràs, Zivojin Jevtic, Frederik Otzen Bagger
Pageof 2
Frequent Collaborators
3 joint publications
Luisa Klemke
3 joint publications
Tiago De Oliveira
3 joint publications
Tamara Isermann
3 joint publications
Florian Wegwitz
2 joint publications
Lena-Christin Conradi
1 joint publications
Özge Çiçek Şener
1 joint publications
Jonathan Seguin
1 joint publications
Rathick Sivalingam
1 joint publications
Matheus Filgueira Bezerra
1 joint publications
Amber Louwagie
